Barclays logo
Barclays

June 4, 2026

Americas Small Cap Research Summary

Market ReportEquitiesHealth CareConsumer Discretionary

This Barclays summary covers key rating and price target changes for Americas small-cap stocks including Alpha Tau, ODDITY Tech, and Sprinklr as of June 4, 2026.

Key Takeaways

  • 1.Alpha Tau's price target was raised to $17.00 following a Tolmar commercialization deal and US trial plan approval for prostate cancer.
  • 2.ODDITY Tech's price target was slashed from $13.00 to $8.00 as it continues to struggle with its largest advertising partner dislocation.
  • 3.Inventiva (IVA) is expected to have a pivotal Phase 3 readout in 4Q for MASH F2/3, which Barclays views as likely successful.

Table of Contents

  • Summary of Changes
  • Company Research
  • Publications Summary
  • Consumer
  • U.S. CHPC & Beverages
  • Healthcare
  • Technology
  • Analyst(s) Certification(s)
  • Important Disclosures

Access the Full Report

Get unlimited access to institutional research reports with a 14-day free trial.

Authors

Lauren R. LiebermanBrandt MontourLukas ShumwayEtzer DaroutEliana MerleRaimo Lenschow

Securities

DRTSODDVACIVAKURACXM

Themes

Small Cap Biotechnology CatalystsDirect-to-Consumer Advertising Risks

Regions

North AmericaUnited States